Home >

Welcome to ASCO Connection Discussion

LOGIN TO START A DISCUSSION
Practice
Mark R. Hutchins, MD
Apr 26, 2016 10:50 PM
 
Has there ever been a PRCT of AC/T vs "other" in a pure TNBC stratified group (in the NeoAdj setting or the Adj setting?) showing that AC/T vs "other" showed a superior survival? When we say that AC/T shows a survival advantage, advantage over what?
The origninal AC vs CMF showed little if any...
Molecular Oncology Tumor Board
ASCO University
Apr 13, 2016 9:33 AM
Read more to answer the following questions: 1) What are available second line therapy options? 2)  Do you test for PD-L1 prior to recommending therapy? 3) Does smoking history affect your treatment recommendations?
Molecular Oncology Tumor Board
ASCO University
Mar 09, 2016 9:36 AM
Read more to answer the following questions: 1) What molecular testing on tissue should be performed in newly diagnosed DLBCL? 2) How need for molecular testing affects tissue requirements and biopsy size? 3) What staging studies and serum biomarkers would you obtain?  
International
ASCO International Affairs
Mar 02, 2016 2:32 PM
ASCO partnered with local organizers to hold two Multidisciplinary Cancer Management Courses (MCMC) in the fall of 2015. The evaluation results for both courses indicate that the majority of respondents intend to make practice changes, and gained new knowledge and skills as a result of attending...
ASCO University
William Nassib William, Jr., MD
Feb 17, 2016 12:48 PM
Welcome to this discussion forum for the Metastatic Squamous Cell Lung Cancer Tumor Board. This course discussed a 63 year old woman with a history of hypertension who presented to her primary care physician with a two-month history of shortness of breath on moderate exertion and a dry cough. The...

Pages

Tweets from ASCO

Tweets from Oncology Community